Publication: Juice of Eclipta prostrata inhibits cell migration in vitro and exhibits anti-angiogenic activity in vivo
1
item.page.dc.date.issued
2008-05-01
item.page.dc.type
item.page.dc.identifier.issn
0258851X
item.page.dc.identifier.other
2-s2.0-45949087186
item.page.dc.rights
Mahidol University
item.page.dc.rights.holder
SCOPUS
item.page.dc.identifier.citation
In Vivo. Vol.22, No.3 (2008), 363-368
punsarn.item.page.citation
Kriengsak Lirdprapamongkol, Jan Peter Kramb, Daranee Chokchaichamnankit, Chantragan Srisomsap, Rudee Surarit, Monnipha Sila-Asna, Ahnond Bunyaratvej, Gerd Danhardt, Jisnuson Svasti Juice of Eclipta prostrata inhibits cell migration in vitro and exhibits anti-angiogenic activity in vivo. In Vivo. Vol.22, No.3 (2008), 363-368. Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/19683
Research Projects
Organizational Units
Authors
Journal Issue
relationships.isThesisOf
item.page.dc.title
Juice of Eclipta prostrata inhibits cell migration in vitro and exhibits anti-angiogenic activity in vivo
item.page.dc.description.abstract
Background: The invasion of cancer cells is critical for metastasis. The effects of Eclipta prostrata, a Thai medicinal plant, on invasion, migration and adhesion of cancer cells were investigated and:i the anti-angiogenic activity in vivo was evaluated. Materials and methods: In vitro invasion and migration assays were performed in modified Boyden chambers. In vivo anti-angiogenic activity was determined using the chick chorioallantoic membrane (CAM) assay. Results: E. prostrata juice inhibited cancer invasion and migration, without affecting cell adhesion. Cell migration was inhibited in a variety of cancer cell types and in endothelial cells, with IC50 values of 31-70 μg/ml, much lower than the IC50 values for cytotoxicity of 203-1,217 μg/ml for cancer cells and >4,000 μg/ml for endothelial cells. Fifty percent inhibition of angiogenesis by E. prostrata juice was observed at 200 μg/egg. Conclusion: E. prostrata juice inhibited cancer and endothelial cell migration in vitro and also showed in vivo anti-angiogenic activity.
